Peterlabs Holdings Bhd (XKLS:0171) PS Ratio: 0.43 (As of Jul. 06, 2026)


XKLS:0171 Peterlabs Holdings Bhd XKLS:0171
47 GF Score
Price RM0.24
View Full Analysis

What is Peterlabs Holdings Bhd PS Ratio?

Peterlabs Holdings Bhd XKLS:0171 47 PS Ratio is 0.43 as of Jul. 06, 2026. GuruFocus rates XKLS:0171 with a GF Score™ of 47/100. Among 952 Drug Manufacturers companies, Peterlabs Holdings Bhd ranks better than 90.13% on this metric.

The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, Peterlabs Holdings Bhd's share price is RM0.24. Peterlabs Holdings Bhd's Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2025 was RM0.55. Hence, Peterlabs Holdings Bhd's PS Ratio for today is 0.43.

The historical rank and industry rank for Peterlabs Holdings Bhd's PS Ratio or its related term are showing as below:

XKLS:0171's PS Ratio is not ranked *
in the Drug Manufacturers industry.
Industry Median: 2.315
* Ranked among companies with meaningful PS Ratio only.

Peterlabs Holdings Bhd's Revenue per Sharefor the three months ended in Jun. 2025 was RM0.12. Its Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2025 was RM0.55.

Back to Basics: PS Ratio


Peterlabs Holdings Bhd  (XKLS:0171) PS Ratio Explanation

The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.

When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.

Similar to the PE Ratio or Price-to-Operating-Cash-Flow or Price-to-Free-Cash-Flow , the PS Ratio measures the valuation based on the earning power of the company. This is where it is different from the PB Ratio , which measures the valuation based on the company's balance sheet.


Be Aware

The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.


Peterlabs Holdings Bhd PS Ratio Related Terms


Peterlabs Holdings Bhd PS Ratio Historical Data

* Premium members only.

The historical data trend for Peterlabs Holdings Bhd's PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Peterlabs Holdings Bhd PS Ratio Chart

Peterlabs Holdings Bhd Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.46 0.65 0.33 0.33 0.31

Peterlabs Holdings Bhd Quarterly Data
Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25
PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.33 0.30 0.30 0.31 0.75

XKLS:0171 vs ZTS, UTHR, VTRS: PS Ratio Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Peterlabs Holdings Bhd's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Peterlabs Holdings Bhd PS Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Peterlabs Holdings Bhd's PS Ratio distribution charts can be found below:

* The bar in red indicates where Peterlabs Holdings Bhd's PS Ratio falls into.


XKLS:0171
47GF Score
Peterlabs Holdings Bhd XKLS:0171
PS Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Peterlabs Holdings Bhd PS Ratio Calculation

The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.

Peterlabs Holdings Bhd's PS Ratio for today is calculated as

PS Ratio=Share Price/Revenue per Share (TTM)
=0.24/0.553
=0.43

Peterlabs Holdings Bhd's Share Price of today is RM0.24.
Peterlabs Holdings Bhd's Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was RM0.55.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

PS Ratio=Market Cap/Revenue

The Revenue here is for the trailing 12 months.

Frequently Asked Questions Learn more about PS Ratio →
What does a PS Ratio of 0.43 mean?
Peterlabs Holdings Bhd (XKLS:0171) has a PS Ratio of 0.43 as of Jul. 06, 2026. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Peterlabs Holdings Bhd and its competitors. According to the industry distribution chart, Peterlabs Holdings Bhd ranks #94 out of 952 companies in the Drug Manufacturers industry, placing it in the top 9.9%.
Is Peterlabs Holdings Bhd's PS Ratio too high?
Peterlabs Holdings Bhd's current PS Ratio is 0.43. The Drug Manufacturers industry median PS Ratio is 2.32. Peterlabs Holdings Bhd's value of 0.43 is 81.4% below this industry median. Based on the distribution chart, Peterlabs Holdings Bhd ranks #94 out of 952 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Peterlabs Holdings Bhd has a GF Score™ of 47/100, reflecting its overall financial health beyond just this single metric.
How does Peterlabs Holdings Bhd's PS Ratio compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Peterlabs Holdings Bhd ranks #94 out of 952 companies for PS Ratio. This places Peterlabs Holdings Bhd in the top 10% of its industry — outperforming the majority of peers. The industry median PS Ratio is 2.32. Peterlabs Holdings Bhd's value of 0.43 is 81.4% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PS Ratio for a Drug Manufacturers company?
The median PS Ratio among Drug Manufacturers companies is 2.32, based on 952 companies in the industry. Companies in the top quartile (top 25%) have a PS Ratio significantly above this median, while those in the bottom quartile fall well below. However, PS Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Peterlabs Holdings Bhd's current PS Ratio of 0.43 is 81.4% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PS Ratio mean?
A high PS Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Peterlabs Holdings Bhd and its competitors. For the Drug Manufacturers industry, the median PS Ratio is 2.32 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Peterlabs Holdings Bhd's current PS Ratio is 0.43. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Peterlabs Holdings Bhd stock overvalued right now?
Peterlabs Holdings Bhd (XKLS:0171) has a current PS Ratio of 0.43. The current PS Ratio is 0.43 and 81.4% below the Drug Manufacturers industry median of 2.32. Peterlabs Holdings Bhd's overall GF Score™ is 47/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PS Ratio calculated?
PS Ratio is calculated from a company's financial statements. For Peterlabs Holdings Bhd (XKLS:0171), the current PS Ratio is 0.43 as of Jul. 06, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Peterlabs Holdings Bhd Business Description

Address Jalan Nilam 3, Lot 16014 (PT No. 24341), Bandar Nilai Utama, Nilai, NSN, MYS, 71800
Peterlabs Holdings Bhd is engaged in the manufacturing, distribution, export, and trading of animal health and nutrition products. The Group offers biosecurity and disinfectants, compound feed supplements, feed additives, nutritional premixes, pharmaceuticals, and water-soluble supplements, as well as farm management, technical advisory services, raw material analysis, and feed formulation. Its segments are Manufacturing, which covers the manufacturing and distribution of animal health and nutrition products; Trading, which involves the trading and distribution of animal health and nutrition products and consumer goods, and contributes the majority of its revenue; and Others, which provides investment holding services. The company operates in Malaysia and internationally.
47GF Score

Get the complete analysis for XKLS:0171

PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

RM0.24
Price